Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Immunohistochemical Analysis Of S-phase Cells In Normal Human And Rat Liver By PC10 Monoclonal Antibody.
R. Mancini, L. Marucci, A. Benedetti, A. Jézéquel, F. Orlandi
Published 1994 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
The expression of proliferating cell nuclear antigen (PCNA) was examined in normal human and rat liver fixed in either formaldehyde or methanol, and was compared with the incorporation of bromodeoxyuridine (BrdU) in S-phase cells. Codistribution of PCNA and BrdU was assessed in rat liver by double immunohistochemical staining using PC10 and anti-BrdU monoclonal antibodies to identify labelled nuclei of parenchymal and sinusoidal cells. In formaldehyde-fixed human biopsies (n = 13) PCNA-labelling index (PCNA LI) was 0.43 +/- 0.24% (mean +/- SEM) for hepatocytes and 0.09 +/- 0.03% for sinusoidal cells. A great interspecimen variability was observed and a preferential lobular distribution was not evident. In methanol-fixed human liver (n = 8) the immunostaining was strong. PCNA LI was 0.05 +/- 0.01% for hepatocytes and 0.14 +/- 0.01% for sinusoidal cells. 75% of labelled hepatocytes and 60% of labelled sinusoidal cells were found in acinar zone 1. In formaldehyde-fixed rat liver (n = 10) a weak nuclear staining and a great interspecimen variability were evident. LI was 0.13 +/- 0.07% for hepatocytes and 0.40 +/- 0.21% for sinusoidal cells without preferential acinar distribution. In methanol-fixed rat liver (n = 10), PCNA LI was 0.14 +/- 0.02% for hepatocytes and 0.40 +/- 0.04% for sinusoidal cells. 64% of labelled hepatocytes and 50% of labelled sinusoidal cells were found in zone 1. Only on methanol-fixed material did double immunohistochemistry show an almost complete overlap of BrdU and PCNA labelling. The PCNA LIs and the zonal distribution of labelled nuclei as obtained in methanol-fixed material are in keeping with previous reports using 3H-thymidine (3H-Thy) incorporation, suggesting that PCNA immunostaining represents a valid alternative to 3H-Thy.(ABSTRACT TRUNCATED AT 250 WORDS)
This paper references
Increased uptake of bromodeoxyuridine by hepatocytes from early stage of primary biliary cirrhosis.
K. Tarao (1991)
Eukaryotic DNA replication. Enzymes and proteins acting at the fork.
P. Thömmes (1990)
Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.
J. Celis (1985)
Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.
E. Tan (1989)
Review: assessment of cell proliferation in histological material.
P. Hall (1990)
Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites
R. Bravo (1987)
Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labeling index in mouse lung tissues
L. G. Thaete (2004)
Autoantibody to a nuclear antigen in proliferating cells.
K. Miyachi (1978)
Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: A study of proliferating cell nuclear antigen expression
H. K. Wolf (1992)
Detection of proliferating liver cells in various diseases by a monoclonal antibody against DNA polymerase‐α: With special reference to the relationship between hepatocytes and sinusoidal cells
S. Seki (1991)
Detection of proliferating hepatocytes in patients with acute hepatic failure by mitotic figures and a monoclonal antibody against DNA polymerase alpha.
S. Seki (1991)
Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.
R. Garcia (1989)
5-Bromodeoxyuridine-induced carcinogenesis and its modification by persistent estrus syndrome, unilateral nephrectomy, and X-irradiation in rats.
N. Napalkov (1989)
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
J. Cordell (1984)
Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues
P. Galand (1989)
Introduction of monoclonal antibodies to bromodeoxyuridine to monitor hepatic regeneration.
M. Nishida (1991)
Intranuclear co-location of newly replicated DNA and PCNA by simultaneous immunofluorescent labelling and confocal microscopy in MCF-7 cells.
C. Humbert (1992)
Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA
G. Prelich (1988)
Primary liver neoplasms: Evaluation of proliferative index using MoAb Ki 67
W. Grigioni (1989)
The streaming liver. II. Hepatocyte life history.
N. Arber (1988)
Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining
G. Koukoulis (1992)
Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication.
R. Bravo (1985)
Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ
R. Bravo (1987)
Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication.
R. Bravo (1986)
The clinical assessment of proliferation and growth in human tumours: Evaluation of methods and applications as prognostic variables
C. Quinn (1990)
Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form.
N. Waseem (1990)
Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen
T. Terada (1992)
Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein
G. Prelich (1987)
Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde.
N. Kawakita (1992)
Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis.
G. Landberg (1991)
Regulation of proliferating cell nuclear antigen during the cell cycle.
G. Morris (1989)
Cell cycle kinetic studies in human cancers. Development of three DNA-specific labels in three decades.
A. Raza (1991)
Proliferating cell nuclear antigen expression in normal, preneoplastic, and neoplastic colonic epithelium of the rat.
K. Yamada (1992)
Monoclonal antibody Ki‐67: its use in histopathology
D. C. Brown (1990)
Measuring cell proliferation.
Woosley Jt (1991)
Cyclin (PCNA, auxiliary protein of DNA polymerase δ) is a central component of the pathway(s) leading to DNA replication and cell division
J. Celis (1987)
A rapid, accurate, immunohistochemical method to label proliferating cells in the digestive tract: A comparison with tritiated thymidine
E. Lacy (1991)
Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.
B. Robbins (1987)
Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms
P. A. Hall (1990)
Properties of DNA polymerases delta and epsilon, and their roles in eukaryotic DNA replication.
R. Bambara (1991)
The regulation of chromosome replication
J. Blow (1992)
This paper is referenced by
Synergistic growth inhibition of mouse skin tumors by pomegranate fruit extract and diallyl sulfide: evidence for inhibition of activated MAPKs/NF-κB and reduced cell proliferation.
J. George (2011)
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study.
A. Benedetti (2001)
Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
P. Kennedy (2017)
Bile ductule formation in fetal, neonatal, and infant livers compared with extrahepatic biliary atresia
J. Cocjin (1996)
Inorganic Nanovehicle Targets Tumor in an Orthotopic Breast Cancer Model
G. Choi (2014)
Enhanced chemoprevention by the combined treatment of pterostilbene and lupeol in B[a]P-induced mouse skin tumorigenesis.
Payal Singh (2017)
Dynamic changes in nuclear localization of a DNA-binding protein tyrosine phosphatase TCPTP in response to DNA damage and replication arrest
Nadella Kiran Sree (2012)
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells.
G. Svegliati-Baroni (2001)
Clonal proliferation of hepatocytes during chronic hepatitis B virus infection.
T. Tu (2012)
Cell Nuclear Antigen The AgNOR Method For Grading Of Glial Tumors Value Of Proliferative Immunohistochemistry And Preoperative Histological Glial Tümöderin Preoperatif Histolojik Derecelendirmesinde Proliferatif Hücre Nükleer Antijeni Immünositokimyasi ve AgNOR Yönteminin Yeri
H. Sayrak (2000)
Hepatitis B Virus: Persistence and Clearance
C. Seeger (2016)
The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2.
A. di Sario (2004)
Partial Hepatectomy and Castration of HBV Transgenic Mice.
Y. Tian (2017)
Emerging tools in the changing landscape of chronic hepatitis B management
U. Gill (2019)
Inhibition of the Na 1 /H 1 Exchanger Reduces Rat Hepatic Stellate Cell Activity and Liver Fibrosis: An In Vitro and In Vivo Study
A. Benedetti (2001)
Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
M. Delhaye (1996)
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat
A. di Sario (2003)
Needle biopsy of hepatocellular carcinoma: Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes
F. Chapel (1996)
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
W. Mason (2016)
Tissue Expression of PCNA and Caspase 3 in the Liver in Patients with Chronic Hepatitis , Cirrhosis and Hepatocellular Carcinoma
Maged El Ghanam (2012)
Hepatoprotective and antifibrotic effect of a new silybin-phosphatidylcholine-Vitamin E complex in rats.
A. di Sario (2005)
Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection
T. Tu (2015)
Fate of the human liver after hemihepatic portal vein embolization: Cell kinetic and morphometric study
H. Harada (1997)
Resveratrol and Black Tea Polyphenol Combination Synergistically Suppress Mouse Skin Tumors Growth by Inhibition of Activated MAPKs and p53
Jasmine George (2011)
Transforming Growth Factor-β1 Released from the Spleen Exerts a Growth Inhibitory Effect on Liver Regeneration in Rats
S. Ueda (2003)
Retraction: Resveratrol and Black Tea Polyphenol Combination Synergistically Suppress Mouse Skin Tumors Growth by Inhibition of Activated MAPKs and p53
Jasmine George (2019)
Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis.
S. Naveau (2005)
Antiviral chemotherapy for the treatment of hepatitis B virus infections.
J. Torresi (2000)
Hepatocyte proliferative activity in human liver cirrhosis.
M. Delhaye (1999)
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.
A. Galli (2002)
p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication.
M. S. Serfas (1997)
Molecular biology of hepatitis B virus infection.
C. Seeger (2015)See more